Buyer beware: 7 red flags signal a reckoning in private markets
The warning signs are piling up. Consider, for example Wall Street Journal columnist Jason Zweig's June article, which raised serious questions about valuation practices at Hamilton Lane Private Assets Fund. Zweig revealed Hamilton Lane's use of a valuation methodology that enabled the fund to record generous mark-ups on secondary investments – often within days of purchasing them.
According to the article, the fund recorded significant markups shortly after acquiring positions. Such a move, while not unheard of in private markets, may result in perceptions of artificially boosted returns.
While the Hamilton Lane Private Assets Fund targets individual investors, the underlying valuation and incentive dynamics mirror those seen across segments of the institutional private markets landscape.
Signs of late-stage speculation: Seven red flags
How did this happen? Private markets – which include investments such as venture capital, buyouts, real estate, hedge funds and private credit – were all the rage among institutional investors over the past two decades. But today, seven red flags strongly suggest that private markets are in the late stage of a classic speculative cycle.
At best, this means they are severely overvalued; at worst, it means that at least some segments may qualify as a bubble.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Red flag #1: Widespread acceptance of a flawed narrative
In the late 1990s, Americans believed that any company with a '.com' suffix offered a sure path to riches. In the early 2000s, Americans believed that real estate prices would never decline on a national level.
In the 2020s, it seems almost every institutional and individual investor believes that private markets offer a foolproof way to enhance returns and/or reduce portfolio risk. Few question the validity of this narrative despite mounting evidence that not only is it unlikely to be true in the future, but there is also strong evidence that it failed to materialise in the past.
Red flag #2: Presence of a complacent and siloed supply chain
The real estate bubble in the early 2000s that led to the global financial crisis was extremely difficult to detect because it was visible only to a small handful of people who understood every segment of the real estate and mortgage-backed security supply chain.
Back then, individuals with no real estate experience were using massive amounts of debt to indiscriminately buy properties with the sole intention of flipping them for a quick profit. Mortgage lenders were motivated only by sales volume, which led them to issue loans with little regard for the borrower's ability to pay. Investment banks purchased and repackaged these loans into risky products that were nevertheless rated triple-A.
Finally, lax ratings agencies, specialised insurers, government-sponsored enterprises and the financial media reinforced the faulty narrative, giving speculators a false sense of security.
On the surface, the current supply chain in private markets looks quite different, but it is similar in the sense that each segment adds incremental risk. Few investors appreciate how these risks compound as products move along the assembly line. Moreover, participants in the supply chain are so hyper-focused on extracting value from their segment that they have little care for the risks embedded in the products that pop out at the end.
Rather than focusing solely on the end-recipients of capital flows, however, attention should be directed further upstream towards the mechanisms and decision-makers that enable such behaviours to persist unchecked.
This is why I believe a critical, yet often under-examined, link in the private markets supply chain lies with investment consulting firms and investment plan staff. For more than two decades, many have encouraged trustees to steadily increase private markets allocations, often beyond what long-term objectives or market conditions justify.
In some cases, these recommendations have relied on optimistic return assumptions, cursory due diligence and incentive structures that may not align with beneficiaries' long-term interests. Importantly, these entities tend to operate with limited regulatory oversight.
Red flag #3: Large, indiscriminate capital inflows
When attractive investment opportunities are scarce, prices of sound investments rise to unattractive levels. This compels fund managers to allocate the excess to unworthy investments and/or outright frauds. Eventually, a critical mass of investors awakes to this reality; capital flows reverse; and the speculative cycle ends with a crash.
The flood of capital into private markets has persisted for more than two decades. It began soon after the late chief investment officer of the Yale Investments Office, David Swensen, published Pioneering Portfolio Management in 2000. Followers assumed they could improve their performance by bluntly allocating to alternative asset classes. Few paused to consider the fact that Swensen was both uniquely talented and early to enter these markets. Replicating his performance was never likely for the masses.
Red flag #4: Unbalanced media coverage
Today, mainstream financial coverage tends to emphasise the accessibility and growth potential of private markets, often with limited scrutiny of valuation practices or systemic risks. This consensus-driven approach can reinforce overly optimistic narratives and accelerate momentum in late-stage speculative cycles. This phenomenon is common in financial history.
Red flag #5: Stealthy flight of smart money
On Jun 5, 2025, Bloomberg reported that the Yale Investment Office was nearing a deal to close a sale of US$2.5 billion of its venture capital portfolio. While it is possible that recent funding changes for Ivy League institutions played a role, the scale and timing of Yale's potential sale suggest that other factors such as liquidity management or a re-assessment of valuations may be the more significant drivers. The Yale Investments Office is widely regarded as one of the more astute investors, which makes it plausible that their proposed sale of private equity is a dash for the exit.
Red flag #6: Aggressive sales to retail investors
Starting in the early 1900s, it became common for speculative cycles to end after Wall Street firms exhausted the funds of the last and most vulnerable cohort of capital providers – retail investors. The most common vehicle used to extract capital from retail investors has been the investment company, now more commonly referred to as a mutual fund or 40-Act fund.
Over the past 25 years, private markets were largely reserved for institutional investment plans and ultra-high-net-worth investors. But as is always the case in speculative cycles, overly enthusiastic investors eventually flooded the market with excess capital. The classic cycle of overbuilding and malinvestment ensued.
Now, over-allocated institutional investment plans and private fund managers are desperately seeking exits, which helps explain their sudden interest in bringing private markets to retail investors. Once again, a vehicle of choice is the 40-Act fund. Heavy marketing to retail investors has led to massive inflows into evergreen funds with fancy names, such as interval funds and continuation funds.
Red flag #7: Sudden loss of confidence in the narrative
Speculative cycles end when a critical mass of investors suddenly lose faith in the flawed narrative on which it was based.
In this context, Zweig's article may serve as a valuable warning. Whether the valuations represent isolated practices or broader systemic issues remains to be seen. But the questions raised deserve a closer look by all participants in the capital markets ecosystem.
The place to stop the trouble
Researching the 235-year financial history of the United States trained me to never ignore the red flags that typically signal the approaching end of a speculative cycle.
In 2025, it remains unclear whether the surge of capital into private markets constitutes a full-blown bubble, but the accumulation of red flags strongly suggests that extreme caution is warranted. The sheer volume of capital – combined with extraordinarily high fee structures relative to traditional asset classes – may significantly impair future returns. In this context, the cost of staying on the sidelines seems to pale in comparison to the risks of participation.
Retail investors should approach these increasingly accessible vehicles with a clear understanding of their true purpose and risks. It seems highly likely that, in general, these vehicles are viewed as acceptable exit routes for institutional investors but are likely to constitute unattractive entry points for retail investors.
This is not a scenario that investors should take lightly if advisers present them with opportunities to enter these markets.
The writer is a senior vice-president for IFA Institutional where he specialises in providing advisory services to institutional plans, such as endowments, foundations, pension plans and various corporate plans. This column has been adapted from an article that first appeared in Enterprising Investor at https://blogs.cfainstitute.org/investor
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


AsiaOne
3 hours ago
- AsiaOne
Praise Trump and speak simply: How the South Korean team negotiated its trade deal, Asia News
SEOUL — The South Korean ministers tasked with negotiating a last-ditch trade deal with US President Donald Trump said that to prepare they role-played and solicited tips for engaging with the unpredictable leader. Among the advice they received? Call Trump a "great person" and speak as simply as possible, Industry Minister Kim Jung-kwan told reporters in Washington after the deal was announced on Wednesday (July 30). The stakes were particularly high for South Korea, a major export-driven economy, and Kim and other members of the delegation have only been on the job for a few weeks after President Lee Jae-myung won a snap election in June. Kim called Trump a "master of negotiations" and said each of the team, which included Finance Minister Koo Yun-cheol and Minister for Trade Yeo Han-koo, took turns role-playing as the US president to prepare. "We tried to talk like President Trump, and President Trump's way of talking is very terse and straightforward," Kim said. "We prepared a lot of scenarios on our own on how to answer this or that question." Koo said the team only knew for sure they would be meeting Trump when they saw it on social media. The meeting itself went for about half an hour and the two sides went back and forth on the amount of the investment fund, which was eventually settled at US$350 billion (S$454 billion), Koo said. "We collected a lot of negotiation strategies used by our counterparts in advance and thought a lot about how to respond, so the negotiation was very smooth," he said. Yeo quoted Trump as saying his personal involvement is rare in dealing with officials who are not heads of state, and means "he respects South Korea very much and attaches great importance to South Korea." Earlier in the talks the US had pressed South Korea to lift restrictions on imports derived from cattle older than 30 months, but Yeo helped defuse that by showing the Americans a photo of massive protests that occurred years ago over concerns about mad cow disease. "I think it helped them to understand the situation in Korea," Kim said. [[nid:720806]]
Business Times
4 hours ago
- Business Times
Trump pressures 17 pharma CEOs to cut US drug prices
[WASHINGTON] President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White House said on Thursday. Trump signed a sweeping executive order in May demanding drugmakers cut US medicine prices to match those abroad, saying that if companies did not comply, the government could use rulemaking to bring prices down or pursue other measures, such as importing cheaper medicines from overseas. Trump sent the letters to the chief executives of Eli Lilly, Sanofi, Regeneron, Merck & Co, Johnson & Johnson and AstraZeneca, among others, the White House said. 'Most proposals my Administration has received to 'resolve' this critical issue promised more of the same; shifting blame and requesting policy changes that would result in billions of dollars in handouts to industry,' Trump wrote in the letters, copies of which were posted on his Truth Social account. Shares of Pfizer, Eli Lilly and Gilead Sciences closed down about 2 per cent each, while the NYSE Arca Pharmaceutical Index fell 3 per cent on Thursday. Trump called on drugmakers to provide so-called most-favoured-nation prices to every patient enrolled in the government Medicaid health programme for low-income people, and to guarantee such pricing for new drugs. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up The policy is aimed at cutting US prescription drug prices to the lowest possible price paid by members of the Organisation for Economic Co-operation and Development, which includes most of the world's largest economies. Trump also said companies must return excess overseas revenue from raising prices in other countries to offset lower prices in the US to American patients and taxpayers through an agreement with the government. He is requiring drugmakers to stipulate they would not offer other developed nations better prices than what they offer the United States, and said his administration would provide ways to cut out middlemen and sell directly to patients, provided they do so at most-favoured-nation prices. Trump gave companies until Sept 29 to respond with binding commitments to those terms. 'If you refuse to step up, we will deploy every tool in our arsenal to protect Americans from abusive drug pricing practices,' he warned. Analysts, lobbyists and drug pricing experts said it seemed unlikely that the pharmaceutical companies would comply with Trump's demand to lower US prices. 'I might expect them to try to determine if any of their current products might be made available via direct sales (one of the requests) at a lower price than currently available in the US,' said Stacie Dusetzina, professor of health policy at Nashville's Vanderbilt University. UBS analyst Trung Huynh said Trump's letters were a repeat of earlier demands and played down any likely industry impact, calling it 'just another shot in the dark.' Trump has already pushed for voluntary changes and some companies have pledged to build new US manufacturing plants. US patients pay by far the most for prescription medicines, often nearly three times more than in other developed nations. The country also invests heavily in pharmaceutical research and development. Drugmakers have said drastic price cuts would stifle innovation. Pharmaceutical companies including Pfizer, Novartis, AbbVie and German Merck KGaA's US division, EMD Serono, said they were open to working with the Trump administration. Pfizer is working closely with the Trump Administration and Congress to improve access and affordability for American patients, said spokeswoman Amy Rose. 'Our discussions have been productive,' she said. REUTERS

Straits Times
10 hours ago
- Straits Times
US end of parcel tax relief threatens eBay, Etsy trade
Sign up now: Get ST's newsletters delivered to your inbox LONDON/NEW YORK - Americans shopping for secondhand, vintage or handmade items on platforms like eBay and Etsy face steep customs duties on international purchases in August, potentially hurting trade on those peer-to-peer sites. In a surprise move late on July 30, US President Donald Trump ordered the removal of 'de minimis' duty-free treatment on parcels under US$800 (S$1,000) from all countries, starting Aug 29 - bringing forward a change previously set for July 2027. The acceleration follows pressure from groups that argue the exemption facilitates fentanyl smuggling and has led to a flood of cheap products entering the US duty-free, undermining US retailers and manufacturers. Mr Trump ended duty-free access for low-value parcels from China and Hong Kong at the start of May, disrupting ecommerce flows for online retailers like Shein and Temu. According to Customs and Border Protection, 1.36 billion shipments entered the US under de minimis in 2024, for a total value of US$64.6 billion. eBay and Etsy were among US businesses that spoke out against the policy when CBP asked for feedback on the proposal to remove de minimis. 'These exemptions are a powerful tool that helps small creators, artisans, and makers participate in and navigate cross-border trade,' Etsy's global head of public policy and advocacy, Mr Jeffrey Zubricki, wrote in a submission to CBP in March. Top stories Swipe. Select. Stay informed. Singapore 'For one last time, let's go home': Tears, laughs as last scheduled Jetstar Asia flight touches down Singapore Over half of job applications by retrenched Jetstar Asia staff led to offers or interviews: CEO Singapore No entry: ICA to bar high-risk, undesirable travellers from boarding S'pore-bound ships, flights Singapore 5 foreign women suspected of trafficking 27kg of cocaine nabbed in Changi Airport Singapore Fallen tree branch damages two Yishun flats, showering one home owner in shattered glass Singapore Man accused of raping woman who hired him to fix lights in her flat claims she made first move Singapore 1 ticket wins $12.8 million Toto jackpot draw Singapore 'Switching careers just as I became a dad was risky, but I had to do it for my family' 'Many American Etsy sellers rely on de minimis to import and export products with key trading partners, sustaining their businesses and generating income to support their families.' The majority of Etsy's 5.6 million active sellers and nearly 90 million buyers are in the US. Etsy did not immediately respond to a request for comment on July 31. eBay also urged the customs agency to reconsider, arguing that de minimis gives American consumers access to 'a global market to find value at lower prices, particularly for used goods and a unique, collectible inventory that is not available domestically'. In a results call on July 30, eBay chief executive officer Jamie Iannone flagged the elimination of de minimis outside of China as a potential disruption that may impact revenue. eBay did not immediately respond to a request for comment. Goods shipped through the postal system will face one of two tariffs: either an 'ad valorem duty' equal to the effective tariff rate of the package's country of origin or, for six months, a specific tariff of US$80 to US$200 depending on the country of origin's tariff rate. It is the latest headache for small businesses grappling with hefty import tariffs imposed by Mr Trump, driving up costs, forcing many to hike prices and fuelling concerns that Americans will be paying more for everyday goods. 'The complexity of doing business with the US has gone to levels nobody could have imagined,' said Mr Andrew Wilson, deputy secretary general of the International Chamber of Commerce. He also questioned whether US authorities can handle the tariff collections, potentially leading to delays and backlogs. 'Is border trade equipped to manage the checks and duties collection? If not, what happens with customs backlogs? It's a huge additional burden from next month,' said Mr Wilson. REUTERS